Mobile Menu

Search Results

Search results for: Case Study

The canSAR Knowledgebase for Drug Discovery

In 2011 researchers, from The Institute of Cancer Research UK, created the largest, public, cancer drug discovery resource, known as […]

Eliminating Racial Disparities in Drug Development for Multiple Myeloma

African Americans are at a higher risk of multiple myeloma, yet are underrepresented in clinical trials and benefit less from […]

Digital health information disparities in older adults

We summarise a recent article, published in the Journal of Racial and Ethnic Health Disparities, that explored access to digital […]

Age bands in paediatric medicines

We summarise a recent article, published in BMJ, that explored why certain age bands used for children in paediatric studies […]

EMR implementation in cancer care

We summarise a recent study, published in BMC Health Services Research, that explored the factors influencing the adoption of an […]

Deep learning for drug repurposing

Drug repurposing is an effective strategy to identify new uses for existing drugs. Ohio State University researchers have now created […]

AI explainability in healthcare

AI explainability is one of the most discussed topics when it comes to applying AI in healthcare. Here, we summarise […]

Developing drugs for Parkinson’s disease

Current treatments for Parkinson’s disease are mainly dopaminergic drugs. However, these are limited by several side effects and can only […]

Data-driven eligibility criteria for COVID-19 clinical trials

We summarise a recent article, published in Journal of the American Medical Informatics Association, that evaluated the impact of eligibility […]

Real-world evidence in regulatory decision making

Real-world evidence can be used to show that a drug or medical device is safe and effective. The FDA has […]